U.S. sales boost Nycomed to Queen’s Award

Article

Nycomed Amersham received the Queen’s Award for Enterprise, which is given in recognition for a company’s outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st

Nycomed Amersham received the Queen’s Award for Enterprise, which is given in recognition for a company’s outstanding achievement in technology, exports, or environmental performance. Queen Elizabeth grants the awards on her April 21st birthday.

The company’s headquarters are located in the U.K. while its North American operations are headquartered in Princeton, NJ.

The company’s U.K. imaging business group won the award for its continuous achievement in export sales from 1994 to 1999. During this time, Nycomed’s British exports more than doubled. Over half of Nycomed’s success came through sales from the U.S. office. Myoview, a heart imaging agent, and OncoSeed, a treatment for prostate cancer, were best-sellers, said Daniel L. Peters, Nycomed Imaging’s U.S. president. The company has won the Queen’s Award 14 times in the last 33 years.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.